Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Govind Babu, Padmaparna Chaudhuri, Manoj Rajappa, Manjusha Biswas, Bipinesh Sansar, Chethan Rajegowda, Aneesha Radhakrishnan, Jayshree Advani, Biplab Tewary, Padhma Radhakrishnan, Saravanan Thiyagarajan, Aditi Chatterjee, Ram Shankar Upadhayaya & Pradip K Majumder. (2021) JAK-STAT inhibitor as a potential therapeutic opportunity in AML patients resistant to cytarabine and epigenetic therapy. Cancer Biology & Therapy 22:1, pages 66-78.
Read now
Read now
Fumiya Shimamura, Chikuma Hamada, Shigeyuki Matsui & Akihiro Hirakawa. (2018) Two-stage approach based on zone and dose findings for two-agent combination Phase I/II trials. Journal of Biopharmaceutical Statistics 28:6, pages 1025-1037.
Read now
Read now
Kayleigh R. Marx, Hagop Kantarjian & Farhad Ravandi. (2016) Vosaroxin: innovative anticancer quinolone for the treatment of acute myelogenous leukemia. Expert Opinion on Orphan Drugs 4:8, pages 885-892.
Read now
Read now
Christopher R Cogle, Jesse D Ortendahl, Tanya GK Bentley, Ayanna M Anene, Scott Megaffin, Thomas J McKearn, Michael E Petrone & Sudipto Mukherjee. (2016) Cost–effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 275-284.
Read now
Read now
Christopher B. Benton, Farhad Ravandi, Michael Andreeff, Tapan Kadia, Vivian Ruvolo, Peng Qiu, David A. Wheeler, Guillermo Garcia-Manero, Jorge Cortes, Hagop M. Kantarjian & Marina Konopleva. (2014) Case series of patients with acute myeloid leukemia receiving hypomethylation therapy and retrospectively found to have or mutations. Leukemia & Lymphoma 55:6, pages 1431-1434.
Read now
Read now
Alison R. Walker, Rebecca B. Klisovic, Ramiro Garzon, Larry J. Schaaf, Kristina Humphries, Steven M. Devine, John C. Byrd, Michael R. Grever, Guido Marcucci & William Blum. (2014) Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia. Leukemia & Lymphoma 55:6, pages 1304-1308.
Read now
Read now
Jakob R. Passweg, Thomas Pabst, Sabine Blum, Mario Bargetzi, Qiyu Li, Dominik Heim, Georg Stussi, Michael Gregor, Leda Leoncini, Sandrine Meyer-Monard, Peter Brauchli & Yves Chalandon. (2014) Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07). Leukemia & Lymphoma 55:1, pages 87-91.
Read now
Read now
May Kung Sutherland, Changpu Yu, Martha Anderson, Weiping Zeng, Nico van Rooijen, Eric L. Sievers, Iqbal S. Grewal & Che-Leung Law. (2010) 5-Azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia. mAbs 2:4, pages 440-448.
Read now
Read now
Articles from other publishers (24)
Takanori Fukunaga, Yuki Fujita, Haruhiko Kishima & Toshihide Yamashita. (2018) Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma. PLOS ONE 13:11, pages e0206552.
Crossref
Crossref
Björn Tampe & Michael Zeisberg. (2018) Chromatin dynamics at the core of kidney fibrosis. Matrix Biology 68-69, pages 194-229.
Crossref
Crossref
Birgul Onec, Harika Okutan, Murat Albayrak, Esra Saribacak Can, Vedat Aslan, Basak Unver Koluman, Ozge Soyer Kosemehmetoglu & Aynur Albayrak. (2018) Combination therapy with azacitidine, etoposide, and cytarabine in the treatment of elderly acute myeloid leukemia patients. Journal of Cancer Research and Therapeutics 14:5, pages 1105-1111.
Crossref
Crossref
Jie Wu, Guangchuan Wang, Baojun He, Xuejun Chen & Yuzhi An. (2017) Methylation of the UNC5C gene and its protein expression in colorectal cancer. Tumor Biology 39:4, pages 101042831769756.
Crossref
Crossref
Figen Atalay & Elif Birtaş Ateşoğlu. (2015) Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts (MDS-RAEB2). Indian Journal of Hematology and Blood Transfusion 32:1, pages 46-53.
Crossref
Crossref
I. I. Kostroma, S. V. Gritsaev, Zh. Yu. Sidorova, S. A. Tiranova, S. P. Svitina, Yu. S. Drizhun, Zh. V. Chubukina, I. S. Martynkevich, S. I. Kapustin & S. S. Bessmeltsev. (2016) Aberrant methylation of the promoter regions of the SOX7 and p15INK4b genes and Wnt signaling pathway antagonists in patients with acute myeloid leukemias. Terapevticheskii arkhiv 88:7, pages 31.
Crossref
Crossref
P. Raha. 2016. Medical Epigenetics. Medical Epigenetics
799
826
.
Michel Neidhart. 2016. DNA Methylation and Complex Human Disease. DNA Methylation and Complex Human Disease
419
427
.
Thomas Prebet & Steven D. Gore. 2015. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy
169
187
.
Wenji Yan & Mingzhou Guo. 2015. Cancer Epigenetics. Cancer Epigenetics
405
424
.
Naveen Pemmaraju, Guillermo Garcia-Manero & Farhad Ravandi. 2015. Targeted Therapy of Acute Myeloid Leukemia. Targeted Therapy of Acute Myeloid Leukemia
441
458
.
Amer M. Zeidan, Mohamed A. Kharfan-Dabaja & Rami S. Komrokji. (2014) Beyond hypomethylating agents failure in patients with myelodysplastic syndromes. Current Opinion in Hematology 21:2, pages 123-130.
Crossref
Crossref
Takayuki Ishikawa. (2013) Novel therapeutic strategies using hypomethylating agents in the treatment of myelodysplastic syndrome. International Journal of Clinical Oncology 19:1, pages 10-15.
Crossref
Crossref
Antonia M. S. Müller & Mareike Florek. 2014. Small Molecules in Oncology. Small Molecules in Oncology
299
324
.
Amer M. Zeidan, Yuliya Linhares & Steven D. Gore. (2013) Current therapy of myelodysplastic syndromes. Blood Reviews 27:5, pages 243-259.
Crossref
Crossref
Tiffany R. Hodges, Bryan D. Choi, Darell D. Bigner, Hai Yan & John H. Sampson. (2013) Isocitrate dehydrogenase 1: what it means to the neurosurgeon. Journal of Neurosurgery 118:6, pages 1176-1180.
Crossref
Crossref
H. Joachim Deeg, David T. Bowen, Steven D. Gore, Torsten Haferlach, Michelle M. Le Beau & Charlotte NiemeyerAmer M. Zeidan & Steven D. Gore. 2013. Myelodysplastic Syndromes. Myelodysplastic Syndromes
189
210
.
Susan O'Brien, David A. Rizzieri, Norbert Vey, Farhad Ravandi, Utz O. Krug, Mikkael A. Sekeres, Mike Dennis, Adriano Venditti, Donald A. Berry, Tove Flem Jacobsen, Karin Staudacher, Trygve Bergeland & Francis J. Giles. (2012) Elacytarabine has single‐agent activity in patients
with advanced acute myeloid leukaemia. British Journal of Haematology 158:5, pages 581-588.
Crossref
Crossref
Joon Ho Moon, Soo Jung Lee, Yoo Jin Lee, Byung Woog Kang, Yee Soo Chae, Jong Gwang Kim, Jang Soo Suh & Sang Kyun Sohn. (2011) Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blast. Annals of Hematology 91:3, pages 367-373.
Crossref
Crossref
Jason M. Foulks, K. Mark Parnell, Rebecca N. Nix, Suzanna Chau, Krzysztof Swierczek, Michael Saunders, Kevin Wright, Thomas F. Hendrickson, Koc-Kan Ho, Michael V. McCullar & Steven B. Kanner. (2012) Epigenetic Drug Discovery: Targeting DNA Methyltransferases. SLAS Discovery 17:1, pages 2-17.
Crossref
Crossref
Vu Duong & Jeffrey Lancet. 2012. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics
315
348
.
Juan Ren, Brahma N. Singh, Qiang Huang, Zongfang Li, Ya Gao, Prachi Mishra, Yi L. Hwa, Jinping Li, Sean C. Dowdy & Shi-Wen Jiang. (2011) DNA hypermethylation as a chemotherapy target. Cellular Signalling 23:7, pages 1082-1093.
Crossref
Crossref
Brock C. Christensen, Ashley A. Smith, Shichun Zheng, Devin C. Koestler, E. Andres Houseman, Carmen J. Marsit, Joseph L. Wiemels, Heather H. Nelson, Margaret R. Karagas, Margaret R. Wrensch, Karl T. Kelsey & John K. Wiencke. (2011) DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma. JNCI: Journal of the National Cancer Institute 103:2, pages 143-153.
Crossref
Crossref
Xiaojing Yang, Fides Lay, Han Han & Peter A. Jones. (2010) Targeting DNA methylation for epigenetic therapy. Trends in Pharmacological Sciences 31:11, pages 536-546.
Crossref
Crossref